Chronic fluoxetine treatment impairs motivation and reward learning by affecting neuronal plasticity in the central amygdala
Background and Purpose The therapeutic effects of fluoxetine are believed to be due to increasing neuronal plasticity and reversing some learning deficits. Nevertheless, a growing amount of evidence shows adverse effects of this drug on cognition and some forms of neuronal plasticity. Experimental Approach To study the effects of chronic fluoxetine treatment, we combine an automated assessment of motivation and learning in mice with an investigation of neuronal plasticity in the central amygdala and basolateral amygdala. We use immunohistochemistry to visualize neuronal types and perineuronal nets, along with DI staining to assess dendritic spine morphology. Gel zymography is used to test fluoxetine's impact on matrix metalloproteinase‐9, an enzyme involved in synaptic plasticity. Key Results We show that chronic fluoxetine treatment in non‐stressed mice increases perineuronal nets‐dependent plasticity in the basolateral amygdala, while impairing MMP‐9‐dependent plasticity in the central amygdala. Further, we illustrate how the latter contributes to anhedonia and deficits of reward learning. Behavioural impairments are accompanied by alterations in morphology of dendritic spines in the central amygdala towards an immature state, most likely reflecting animals' inability to adapt. We strengthen the link between the adverse effects of fluoxetine and its influence on MMP‐9 by showing that behaviour of MMP‐9 knockout animals remains unaffected by the drug. Conclusion and Implications Chronic fluoxetine treatment differentially affects various forms of neuronal plasticity, possibly explaining its opposing effects on brain and behaviour. These findings are of immediate clinical relevance since reported side effects of fluoxetine pose a potential threat to patients..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:178 |
|---|---|
| Enthalten in: |
British Journal of Pharmacology - 178(2021), 3, Seite 672-688 |
| Beteiligte Personen: |
Puścian, Alicja [VerfasserIn] |
|---|
| BKL: |
|---|
| Anmerkungen: |
© 2021 The British Pharmacological Society |
|---|
| Umfang: |
17 |
|---|
| doi: |
10.1111/bph.15319 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
WLY002937859 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | WLY002937859 | ||
| 003 | DE-627 | ||
| 005 | 20230307122843.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230213s2021 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1111/bph.15319 |2 doi | |
| 028 | 5 | 2 | |a BPH_BPH15319.xml |
| 035 | |a (DE-627)WLY002937859 | ||
| 035 | |a (WILEY)BPH15319 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 082 | 0 | 4 | |a 610 |q ASE |
| 084 | |a 44.38 |2 bkl | ||
| 084 | |a 44.40 |2 bkl | ||
| 100 | 1 | |a Puścian, Alicja |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Chronic fluoxetine treatment impairs motivation and reward learning by affecting neuronal plasticity in the central amygdala |
| 264 | 1 | |c 2021 | |
| 300 | |a 17 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © 2021 The British Pharmacological Society | ||
| 520 | |a Background and Purpose The therapeutic effects of fluoxetine are believed to be due to increasing neuronal plasticity and reversing some learning deficits. Nevertheless, a growing amount of evidence shows adverse effects of this drug on cognition and some forms of neuronal plasticity. Experimental Approach To study the effects of chronic fluoxetine treatment, we combine an automated assessment of motivation and learning in mice with an investigation of neuronal plasticity in the central amygdala and basolateral amygdala. We use immunohistochemistry to visualize neuronal types and perineuronal nets, along with DI staining to assess dendritic spine morphology. Gel zymography is used to test fluoxetine's impact on matrix metalloproteinase‐9, an enzyme involved in synaptic plasticity. Key Results We show that chronic fluoxetine treatment in non‐stressed mice increases perineuronal nets‐dependent plasticity in the basolateral amygdala, while impairing MMP‐9‐dependent plasticity in the central amygdala. Further, we illustrate how the latter contributes to anhedonia and deficits of reward learning. Behavioural impairments are accompanied by alterations in morphology of dendritic spines in the central amygdala towards an immature state, most likely reflecting animals' inability to adapt. We strengthen the link between the adverse effects of fluoxetine and its influence on MMP‐9 by showing that behaviour of MMP‐9 knockout animals remains unaffected by the drug. Conclusion and Implications Chronic fluoxetine treatment differentially affects various forms of neuronal plasticity, possibly explaining its opposing effects on brain and behaviour. These findings are of immediate clinical relevance since reported side effects of fluoxetine pose a potential threat to patients. | ||
| 700 | 1 | |a Winiarski, Maciej |4 aut | |
| 700 | 1 | |a Łęski, Szymon |4 aut | |
| 700 | 1 | |a Charzewski, Łukasz |4 aut | |
| 700 | 1 | |a Nikolaev, Tomasz |4 aut | |
| 700 | 1 | |a Borowska, Joanna |4 aut | |
| 700 | 1 | |a Dzik, Jakub M. |4 aut | |
| 700 | 1 | |a Bijata, Monika |4 aut | |
| 700 | 1 | |a Lipp, Hans‐Peter |4 aut | |
| 700 | 1 | |a Dziembowska, Magdalena |4 aut | |
| 700 | 1 | |a Knapska, Ewelina |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t British Journal of Pharmacology |g 178(2021), 3, Seite 672-688 |w (DE-627)WLY00292899X |x 14765381 |7 nnns |
| 773 | 1 | 8 | |g volume:178 |g year:2021 |g number:3 |g pages:672-688 |g extent:17 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_WLY | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a SSG-OPC-ASE | ||
| 936 | b | k | |a 44.38 |q ASE |
| 936 | b | k | |a 44.40 |q ASE |
| 951 | |a AR | ||
| 952 | |d 178 |j 2021 |e 3 |h 672-688 |g 17 | ||